Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
GV20 Therapeutics
DualityBio Inc.
Incyte Corporation
Marengo Therapeutics, Inc.
OncoC4, Inc.
National Cancer Institute (NCI)
Salubris Biotherapeutics Inc
Pfizer
Xencor, Inc.
Incyte Corporation
Incyte Corporation
Incyte Corporation
Masonic Cancer Center, University of Minnesota
Case Comprehensive Cancer Center